Literature DB >> 10194176

Inhibition of bronchoprotective effects of beta2-adrenoceptor agonists by peroxynitrite in guinea pig airways.

H Kanazawa1, S Shiraishi, T Okamoto, K Hirata, J Yoshikawa.   

Abstract

Peroxynitrite plays an important role in the pathogenesis of inflammatory diseases, including those affecting the lung. In inflamed airways, simultaneous cellular production of superoxide anion (.O2-) and nitric oxide (NO) may occur, potentially resulting in continuous formation of peroxynitrite. However, because peroxynitrite has a short half-life, its in vivo physiologic effects in the airways may not be sufficiently evaluated with a single administration. Accordingly, this study was designed to use 3-morpholinosydnonimine (SIN-1), a compound that releases peroxynitrite, to determine whether peroxynitrite could alter airway beta2-adrenoceptor (beta2-AR) function in anesthetized guinea pigs. Though SIN-1(10(-)7 M) alone had no effect on pulmonary resistance, pretreatment with SIN-1 significantly attenuated isoprenaline- and salbutamol-induced bronchoprotection against acetylcholine. Pretreatment with SIN-1 also attenuated forskolin-induced bronchoprotection. S-Nitroso-N-acetylpenicillamine (SNAP), a potent NO donor, did not have the same effect as SIN-1. N-Acetylcysteine and glutathione each significantly reversed the inhibitory effect of SIN-1 on isoprenaline-induced bronchoprotection in a dose-dependent manner. These striking findings suggested that peroxynitrite, but not NO, is an important mediator of alteration of beta2-AR function in airway smooth muscle. Additionally, the action of peroxynitrite seems to be directed either at adenylate cyclase activity or at effects downstream of such activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194176     DOI: 10.1164/ajrccm.159.4.9808009

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  3 in total

1.  Decreased peroxynitrite inhibitory activity in induced sputum in patients with bronchial asthma.

Authors:  H Kanazawa; S Shiraishi; K Hirata; J Yoshikawa
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

2.  Loss of salmeterol bronchoprotection against exercise in relation to ADRB2 Arg16Gly polymorphism and exhaled nitric oxide.

Authors:  Matteo Bonini; Perdita Permaul; Tejaswini Kulkarni; Shamsah Kazani; Alex Segal; Christine A Sorkness; Michael E Wechsler; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2013-12-15       Impact factor: 21.405

3.  Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.

Authors:  Joseph Footitt; Patrick Mallia; Andrew L Durham; W Eugene Ho; Maria-Belen Trujillo-Torralbo; Aurica G Telcian; Ajerico Del Rosario; Cheng Chang; Hong-Yong Peh; Tatiana Kebadze; Julia Aniscenko; Luminita Stanciu; Sarah Essilfie-Quaye; Kazuhiro Ito; Peter J Barnes; Sarah L Elkin; Onn M Kon; W S Fred Wong; Ian M Adcock; Sebastian L Johnston
Journal:  Chest       Date:  2016-01-06       Impact factor: 9.410

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.